Brief: Talaris Therapeutics Reports Q4 Loss Per Share Of $0.35

Tourmaline Bio

17/03/2022 20:02

March 17 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES FOURTH QUARTER AND YEAR-END
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.35

Source text for Eikon:  ID:nGNX2m34KP 
Further company coverage:  TALS.O 

 ((Reuters.Briefs@thomsonreuters.com;))